These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12846740)

  • 1. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.
    Riser BL; Cortes P; DeNichilo M; Deshmukh PV; Chahal PS; Mohammed AK; Yee J; Kahkonen D
    Kidney Int; 2003 Aug; 64(2):451-8. PubMed ID: 12846740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.
    Andersen S; van Nieuwenhoven FA; Tarnow L; Rossing P; Rossing K; Wieten L; Goldschmeding R; Parving HH
    Kidney Int; 2005 Jun; 67(6):2325-9. PubMed ID: 15882275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.
    Nguyen TQ; Tarnow L; Andersen S; Hovind P; Parving HH; Goldschmeding R; van Nieuwenhoven FA
    Diabetes Care; 2006 Jan; 29(1):83-8. PubMed ID: 16373901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
    Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
    J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel accurate rapid ELISA for detection of urinary connective tissue growth factor, a biomarker of chronic allograft nephropathy.
    Bao J; Tu Z; Wang J; Ye F; Sun H; Qin M; Shi Y; Bu H; Li YP
    Transplant Proc; 2008 Sep; 40(7):2361-4. PubMed ID: 18790235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
    Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
    Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.
    Nguyen TQ; Tarnow L; Jorsal A; Oliver N; Roestenberg P; Ito Y; Parving HH; Rossing P; van Nieuwenhoven FA; Goldschmeding R
    Diabetes Care; 2008 Jun; 31(6):1177-82. PubMed ID: 18344285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
    Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
    Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney.
    Falke LL; Dendooven A; Leeuwis JW; Nguyen TQ; van Geest RJ; van der Giezen DM; Broekhuizen R; Lyons K; Stoop R; Kemperman H; Schlingemann R; Joles JA; Goldschmeding R
    Matrix Biol; 2012; 31(7-8):421-31. PubMed ID: 23199377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.
    Adler SG; Kang SW; Feld S; Cha DR; Barba L; Striker L; Striker G; Riser BL; LaPage J; Nast CC
    Kidney Int; 2001 Dec; 60(6):2330-6. PubMed ID: 11737607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats.
    Liu BC; Huang HQ; Luo DD; Ma KL; Liu DG; Liu H
    Chin Med J (Engl); 2006 Jun; 119(12):1010-6. PubMed ID: 16805985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y; Wang B; Keum JS; Jaffa AA
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
    Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
    Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
    Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
    Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
    FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.